Plasma; Serum Patents (Class 530/830)

Cross-Reference Art Collections

Cohn fractions (Class 530/831)
  • Patent number: 4623717
    Abstract: Compositions containing thermally sensitive, therapeutically active proteins are pasteurized without substantial loss of therapeutic activity by mixing the protein composition with a pasteurization-stabilizing amount of a sugar or reduced sugar and of an amino acid prior to pasteurization. Pasteurized compositions containing therapeutically active proteins, which have heretofore been unattainable, can be prepared by the method of the invention.
    Type: Grant
    Filed: June 3, 1985
    Date of Patent: November 18, 1986
    Assignee: Miles Laboratories, Inc.
    Inventors: Peter M. Fernandes, John L. Lundblad
  • Patent number: 4614795
    Abstract: Highly purified, biologically active Human Factor VIII:C having specific activities of about 4000-8000 units per milligram of protein is prepared. In the method of preparation, an AHF concentrate is solubilized or equilibrated in an aqueous medium and treated to change the effective Stokes' radius of the Factor VIII:C to an apparently low value and then subjected to a separation from the concentrate. Treatment of the highly purified Factor VIII:C with a mixture of glycosidases causes substantial removal of carbohydrate side chains without reduction of procoagulant activity and with retention of significant in vivo survival time.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: September 30, 1986
    Assignee: University of Rochester
    Inventors: Stephen I. Chavin, Philip J. Fay
  • Patent number: 4588685
    Abstract: The invention involves isolating a food intake suppressant by subjecting blood serum to ultrafiltration transmitting up to a molecular weight of 30,000 daltons, partially evaporating the filtrate, removing the insoluble part from the concentrate obtained, adding trichloroacetic acid up to a concentration of 5 to 25 weight/volume percent to the liquid phase at a temperature of 0.degree. to 10.degree. C., removing the proteins precipitated, subjecting the obtained solution to chromatography on a gel with a void volume below a molecular weight of 4000 daltons, eluting with a solution of pH 6.0 to 7.0, concentrating the biologically active fractions, chromatographing again on a gel with a void volume below a molecular weight of 4000 daltons, fractionating by elution with water, lyophilizing the active fractions, dissolving the lyophilized fractions in a buffer of pH 8.1 to 8.2, adding trypsin and chymotrypsin to the solution in a substantially identical amount of 0.01 to 0.
    Type: Grant
    Filed: July 19, 1984
    Date of Patent: May 13, 1986
    Assignee: Richter Gedeon Vegyeszeti Gyar Rt.
    Inventors: Jozsef Knoll, Janos Nagy, Huba Kalasz, Berta Knoll